Genetic Testing: Disclosure to Patients and Payors and the Risks In Between
- PMID: 36118804
- PMCID: PMC9462907
Genetic Testing: Disclosure to Patients and Payors and the Risks In Between
References
-
- Nat’l Inst. Health First Complete Sequence of a Human Genome April122022https://www.nih.gov/news-events/nih-research-matters/first-complete-sequ....
-
- Hafemeister Thomas L, Spinos Selina. Lean on Me: A Physician’s Fiduciary Duty to Disclose an Emergent Medical Risk to the Patient. 86 Wash. U.L. Rev. 2009;1167:1187.
-
-
See, e.g., Hahn v. Mirda, 54 Cal. Rptr. 3d 527, 532 (Ct. App. 2007); Tresemer v. Barke, 150 Cal. Rptr. 384, 394 (Ct. App. 1978); Wohlgemuth v. Meyer, 293 P.2d 816, 820 (Cal. Dist. Ct. App. 1956) Mangoni v. Temkin, 679 So. 2d 1286, 1288 (Fla. Dist. Ct. App. 1996); Schmucking v. Mayo, 235 N.W. 633, 633 (Minn. 1931); Tracy v. Merrell Dow Pharm., 569 N.E.2d 875, 878 (Ohio 1991); Borderlon v. Peck, 661 S.W.2d 907, 908 (Tex. 1983); Carson v. Fine, 867 P.2d 610, 617-18 (Wash. 1994); State ex rel. Dean v. Cunningham, 182 S.W.3d 561, 566 (Mo. 2006).
-
-
-
Moore v. Webb, 345 S.W.2d 239, 243 (Mo. App. 1961)
-
MeSH terms
LinkOut - more resources
Full Text Sources
Medical